|
Market Closed -
Xetra
12:35:37 2026-10-26 EDT
|
5-day change | 1st Jan Change | ||
| 5.200 EUR | -0.95% |
|
+0.97% | +40.54% |
Company Valuation: MEDICLIN AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 186.2 | 171 | 130.2 | 115 | 175.8 | 247 | - | - |
| Change | - | -8.16% | -23.89% | -11.68% | 52.89% | 40.54% | - | - |
| Enterprise Value (EV) | 186.2 | 171 | 130.2 | 115 | 175.8 | 247 | 247 | 247 |
| Change | - | -8.16% | -23.89% | -11.68% | 52.89% | 40.54% | 0% | 0% |
| P/E | - | - | - | - | - | - | - | - |
| PBR | 1.02x | 0.82x | 0.66x | 0.52x | 0.71x | 0.87x | 0.77x | 0.69x |
| PEG | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 0.28x | 0.24x | 0.18x | 0.15x | 0.22x | 0.31x | 0.31x | 0.3x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.31x | 0.31x | 0.3x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 2.16x | 2.14x | 2.14x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 3.98x | 3.95x | 3.94x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | 0.04 | 0.04 | 0.04 | 0.04 |
| Rate of return | - | - | - | - | 1.08% | 0.77% | 0.77% | 0.77% |
| EPS 2 | - | - | - | - | - | - | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 673.1 | 704.7 | 730.1 | 748.8 | 784.5 | 787.5 | 803.2 | 819.3 |
| EBITDA 1 | 85.22 | 90.92 | 98.73 | 103.8 | 115.6 | 114.3 | 115.3 | 115.6 |
| EBIT 1 | 11.56 | 19.52 | 12.72 | 53.49 | 55.36 | 62.11 | 62.47 | 62.72 |
| Net income 1 | 1.461 | 9.441 | -10.78 | 24.84 | 25.49 | 36.66 | 38.2 | 40.12 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 3.920 | 3.600 | 2.740 | 2.420 | 3.700 | 5.200 | 5.200 | 5.200 |
| Nbr of stocks (in thousands) | 47,500 | 47,500 | 47,500 | 47,500 | 47,500 | 47,500 | - | - |
| Announcement Date | 3/30/22 | 3/31/23 | 3/27/24 | 3/28/25 | 3/27/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | 0.76% | 279M | ||
| 13.6x | 0.41x | 8.58x | 2.85% | 120B | ||
| 15.82x | 1.93x | 9.64x | 0.66% | 102B | ||
| -281.44x | 19.63x | -331.94x | -.--% | 58.23B | ||
| 13.97x | 1.53x | 9.26x | 2.53% | 29.08B | ||
| 23.05x | 2.16x | 12.37x | 0.89% | 26.68B | ||
| 23.47x | 2.61x | 13.23x | 1.37% | 26.61B | ||
| 8.15x | 1.46x | 6.61x | -.--% | 21.62B | ||
| 29.08x | 5.32x | 22.04x | 2.38% | 19.86B | ||
| 20.23x | 1.81x | 9.1x | 3.51% | 18.93B | ||
| Average | -14.90x | 4.09x | -26.79x | 1.49% | 42.24B | |
| Weighted average by Cap. | -24.57x | 4.10x | -37.00x | 1.55% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- MED Stock
- Valuation MEDICLIN AG
Select your edition
All financial news and data tailored to specific country editions
















